When neuroscientist and musician AZA Allsop discovered research by his Yale colleague Joy Hirsch about how group drumming and musical interaction can affect social behavior, he knew there was a ...
Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, claiming that they used its patent-protected technology in their products.
Square Enix has added a few new difficulty options to Final Fantasy 7 Remake Intergrade - but should you use them? Initially introduced in the brand new Xbox and Switch 2 ports of FF7 Remake, ...
PRINCETON, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
CHARLESTON — Gov. Patrick Morrisey has preached the need for healthier lifestyles for West Virginians since taking office last year, but a report released earlier this month by a state task force ...
Hosted on MSN
How to use diminished chords
House Republicans Slam ‘Self-Dealing’ Senate Republican Payday In Funding Bill Dallas Cowboys' Marshawn Kneeland sent 'concerning' text messages prior to his death Power grid warning issued for 11 ...
13.0 percent of total new regular tobacco use in the United States was attributed to cannabis use. (HealthDay News) — Cannabis use in 2017 was associated with regular tobacco use in 2021 among U.S.
This trial tested a new treatment for patients with a type of breast cancer (metastatic breast cancer (MBC)) that is positive for HER2, which means the cancer cells have a specific protein that helps ...
Taylor Swift released her 12th album, The Life of a Showgirl, last week — and before it was even out for a full day, listeners were already pointing out similarities between her new songs and existing ...
The Raleigh teen accused of killing five people and injuring two others in a mass shooting spree in October 2022 will claim that a prescription medicine contributed to his actions, according to a ...
The LINKER-SMM1 trial evaluates linvoseltamab's safety and efficacy in high-risk smoldering multiple myeloma, aiming to delay disease progression. At the 22nd International Myeloma Society annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results